Skin manifestations in autoinflammatory syndromes

Area of Science:

• Immunology
• Genetics
• Dermatology

Background:

• Autoinflammatory diseases are a distinct category of non-infectious, non-allergic, non-autoimmune, and non-immunodeficient inflammatory conditions.
• Familial Mediterranean fever (FMF) is the most prevalent of the initial familial periodic fever syndromes.
• Recent research highlights inflammasome pathway dysregulation leading to increased interleukin-1 (IL-1) activity in these diseases.

Purpose of the Study:

• To define the scope and characteristics of autoinflammatory diseases.
• To explore the genetic and molecular basis, particularly inflammasome involvement.
• To identify common clinical features, including cutaneous manifestations, and therapeutic responses.

Main Methods:

• Review of genetic and molecular analyses of autoinflammatory diseases.
• Clinical observation and classification of syndromes.
• Analysis of treatment outcomes, focusing on IL-1 antagonist therapies.

Main Results:

• Autoinflammatory diseases are increasingly recognized, encompassing rare hereditary and acquired conditions.
• Inflammasome impairment is a common pathogenic mechanism, driving IL-1 dependent inflammation.
• Cutaneous manifestations are frequent, appearing as erysipelas-like erythema, urticaria-like rashes, pyoderma gangrenosum, acne, and aphthous ulcerations.
• Many autoinflammatory diseases demonstrate a favorable response to IL-1 antagonist treatments.

Conclusions:

• Autoinflammatory diseases represent an expanding group of disorders characterized by innate immune system dysregulation.
• Understanding the role of inflammasomes and IL-1 is crucial for diagnosis and treatment.
• Targeting IL-1 pathways offers a promising therapeutic strategy for various autoinflammatory conditions with diverse clinical presentations.